S S Legha

Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.

S S Legha, Sigrid Ring, Omar Eton et al. · Journal of Clinical Oncology · 1998 · 293 citations

Medicine, Oncology, Pharmacotherapy +14

Prognostic factors for survival of patients treated systemically for disseminated melanoma.

Omar Eton, S S Legha, T E Moon et al. · Journal of Clinical Oncology · 1998 · 221 citations

Medicine, Clinical Sciences, Oncology +17

Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults

S S Legha, MJ Keating, KB McCredie et al. · Blood · 1982 · 105 citations · Full text

Medicine, Internal Medicine, Oncology +5

Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma.

Isaiah W. Dimery, S S Legha, Mihran Shirinian et al. · Journal of Clinical Oncology · 1990 · 83 citations

Medicine, Oncology, Cancer Drug Toxicity Management +12

The role of interferon alfa in the treatment of metastatic melanoma.

S S Legha · PubMed · 1997 · 57 citations

Medicine, Immunology, Oncology +14